ARTICLE | Finance
How Bain plans to deploy $1B new fund
Bain Capital’s larger second fund could see firm increasing emphasis on investing in big biopharma spinouts
June 12, 2019 11:55 PM UTC
Bain Capital Life Sciences’ larger second fund could see the firm increasing its emphasis on investing in big biopharma spinouts after its debut fund featured investments in a pair of megarounds by Pfizer spin-offs.
Bain Capital’s Jeffrey Schwartz told BioCentury the firm has closed Bain Capital Life Sciences Fund II with $900 million from external LPs and about $180 million from internal partners, bringing the fund’s total size to just shy of $1.1 billion. ...